The risk of cancer goes up with age, in part because aging impedes the body's ability to detect and destroy cells with ...

Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...

Genetic analysis reveals how chimeric RNA in prostate cancer varies across populations, offering new paths for precision ...

Researchers from the University of Missouri School of Medicine have shed new light on how the uterus develops, leading to a ...

For a long time, scientists thought this cancer came from the ovaries. But this new research, led by Professor Alexander ...

New treatment approach shows potential in reversing lung damage caused by idiopathic pulmonary fibrosis using immune-based ...

Prostate cancer has distinct genetic properties in different groups of men that could be targeted to improve patient outcomes, new research suggests.

Review highlights how vitamin D, particularly its active form calcitriol, modulates immune responses, inflammation, and tumor ...

Research on gastrointestinal diseases, especially cancer, has mainly focused on epithelial cells, which line the surfaces of ...

Researchers have identified a potential new way to treat idiopathic pulmonary fibrosis (IPF), a deadly and currently incurable lung disease that affects more than 3 million people worldwide.

Tulane scientists found that an FDA-approved cancer drug may help the immune system clear out damaged cells that cause lung ...